Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 13Breast 5Other hematologic neoplasm 2Lymphoid 2Thoracic 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 772Leukemia 596Leukemia, Lymphocytic, Chronic, B-Cell 535Precursor Cell Lymphoblastic Leukemia-Lymphoma 485Myelodysplastic Syndromes 408Lymphoma, Non-Hodgkin 265Lymphoma 265Hematologic Neoplasms 251Leukemia, Myelogenous, Chronic, BCR-ABL Positive 232Multiple Myeloma 199Hodgkin Disease 193Lymphoma, Follicular 181Lymphoma, Mantle-Cell 179Lymphoma, B-Cell, Marginal Zone 156Lymphoma, Large B-Cell, Diffuse 155Burkitt Lymphoma 155Recurrence 149Leukemia, Myelomonocytic, Chronic 139Congenital Abnormalities 131Myeloproliferative Disorders 122Waldenstrom Macroglobulinemia 106Neoplasms 97Leukemia, Myeloid, Chronic-Phase 97Lymphoma, Large-Cell, Immunoblastic 91Primary Myelofibrosis 88Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Blast Crisis 80Leukemia, Myeloid, Accelerated Phase 74Anemia, Refractory, with Excess of Blasts 72Lymphoma, T-Cell, Cutaneous 68

Interventions

Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Meningeal Carcinomatosis × Other hematologic neoplasm × Clear all
NCT01596127 2018-05-24

Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System

M.D. Anderson Cancer Center

Phase 1/2 Terminated
4 enrolled 7 charts
CNSOther hematologic neoplasm

Central Nervous System Diseases, Leukemia, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT00523939 2013-06-17

DepoCyt for Active Lymphomatous or Leukemic Meningitis

Duke University

Phase 2 Terminated
4 enrolled 6 charts
CNSLymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, B-Cell, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡